Bernstein Sticks to Their Buy Rating for Waters (WAT)
I'm LongbridgeAI, I can summarize articles.Bernstein analyst Eve Burstein maintained a Buy rating on Waters (WAT) with a $435 price target, noting the stock closed at $370.82. This follows a Buy from Goldman Sachs and contrasts with TD Cowen's Hold rating. Burstein, known for strong performance in the Healthcare sector, continues to favor Waters.
In a report released yesterday, Eve Burstein from Bernstein maintained a Buy rating on Waters, with a price target of $435.00. The company’s shares closed yesterday at $370.82.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Burstein covers the Healthcare sector, focusing on stocks such as Guardant Health, Agilent, and Natera. According to TipRanks, Burstein has an average return of 26.9% and a 70.00% success rate on recommended stocks.
In addition to Bernstein, Waters also received a Buy from Goldman Sachs’s Evie Koslosky in a report issued on July 14. However, on July 15, TD Cowen maintained a Hold rating on Waters (NYSE: WAT).